Assignee
DCPRIME B V
NL·4 granted patents·7 pending applications·12 citations·filing 2013–2022
Top patents by PatentIndex Score
11 records- 0183US11027001B2Therapeutic cancer vaccines derived from a novel dendritic cell lineDCPRIME B V·Filed 2018·Granted Jun 8, 2021·4 cites·17 claims
- 0282US11052144B2Methods of tumor vaccinationDCPRIME B V·Filed 2020·Granted Jul 6, 2021·2 cites·20 claims
- 0380US10064923B2Therapeutic cancer vaccines derived from a novel dendritic cell lineDCPRIME B V·Filed 2013·Granted Sep 4, 2018·4 cites·3 claims
- 0477US11071778B2Combination product for use in tumor vaccinationDCPRIME B V·Filed 2020·Granted Jul 27, 2021·2 cites·20 claims
- 0560US2021346479A1Therapeutic cancer vaccines derived from a novel dendritic cell lineDCPRIME B V·Filed 2021·Application pending·0 cites
- 0656US2021401961A1Methods of tumor vaccinationDCPRIME B V·Filed 2021·Application pending·0 cites
- 0753US2022305100A1Methods of vaccination and use of cd47 blockadeDCPRIME B V·Filed 2022·Application pending·0 cites
- 0852US2022023406A1Combination product for use in tumor vaccinationDCPRIME B V·Filed 2021·Application pending·0 cites
- 0950US2022168407A1Use of tumor-independent antigens in immunotherapiesDCPRIME B V·Filed 2021·Application pending·0 cites
- 1048US2021322471A1In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapyDCPRIME B V·Filed 2021·Application pending·0 cites
- 1138US2015166955A1Method for loading of dendritic cells with class i antigensDCPRIME B V·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DCPRIME B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →